NCT02100553View on ClinicalTrials.gov

Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Healthy

Interventions

DRUG

CE/BZA

CE 0.45mg/BZA 20mg tablets, single dose

DRUG

Itraconazole

Two 100 mg capsules, once daily for 7 days

DRUG

CE/BZA

CE 0.45mg/BZA 20mg tablets, single dose on Day 5

DRUG

CE/BZA

CE 0.45mg/BZA 20mg tablets, single dose

DRUG

Itraconazole

Two 100 mg capsules, once daily for 7 days

DRUG

CE/BZA

CE 0.45mg/BZA 20mg tablets, single dose on Day 5

Trial Locations (2)

33125

SeaView Research, Inc. (Screening Office), Miami

33126

SeaView Research, Inc., Miami

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT02100553 - Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women | Biotech Hunter | Biotech Hunter